Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments.
BMC Cancer
; 22(1): 730, 2022 Jul 04.
Article
in En
| MEDLINE
| ID: mdl-35787263
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pediatrics
/
Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Child
/
Child, preschool
/
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
Canada